Turning Vision Into Reality | Turning Vision Into Reality |
0

No products in the cart.

Turning Vision Into Reality | Turning Vision Into Reality |
0

No products in the cart.

© Copyright 2024 A BIT LAVISH. MAGAZINE EST.2022
Home Moderna

Moderna

2 Articles
Business

NIH Launches Groundbreaking Vaccine Initiative to Combat Cancer

The National Institutes of Health has announced a new initiative aimed at developing a cancer vaccine, marking a significant advancement in oncology and...

2 Mins read
Business

Moderna’s National Cancer Vaccine Initiative Sparks Stock Surge

Moderna's announcement of a national cancer vaccine effort has led to a notable increase in its stock value, reflecting investor optimism in biotechnology...

2 Mins read

Turning Vision into Reality

A BIT LAVISH | MIAMI’S MAGAZINE

Let’s create something exceptional together.

Founded by Francesca Pérez in Miami in 2022, A Bit Lavish is your source for refined, insider perspectives on the city’s high-end culture. From yachts and real estate to health, wellness, and curated news, we cover Miami’s pulse with a clear, confident editorial voice.

Through modern storytelling and genuine access, we highlight ambition, good design, and the people shaping the city. Discover more — with Miami’s Magazine.

Quick Links

get the latest updates and articles directly to your inbox.

Please enable JavaScript in your browser to complete this form.

Copyright © 2024 A BIT LAVISH | Miami's Magazine Est. 2022

All rights reserved.

Privacy Policy • Terms of Use • California & Florida Privacy Rights Summary Notice

Legal Notice: At A Bit Lavish, we pride ourselves on maintaining high standards of originality and respect for intellectual property. We encourage our audience to uphold these values by refraining from unauthorized copying or reproduction of any content, logo, or branding material from our website. Each piece of content, image, and design is created with care and protected under copyright law. Please enjoy and share responsibly to help us maintain the integrity of our brand. For inquiries on usage or collaborations, feel free to reach out to us +1 305.332.1942.

Translate »